In neurodegenerative diseases such as AD, treatment with non-steroidal anti-inflammatory drugs (NSAIDs) has been reported 42 and COX-1 and COX-2 are the targets of those drugs. This evidence concerns the gene PTGS1 and neurodegenerative disease.